Latest Regulatory Approvals News

Riversgold has kicked off a focused nine-day diamond drilling campaign at its Northern Zone Gold Project near Kalgoorlie to gather essential rock strength data for pit design, as it nears a key mining lease grant and development partnership with MEGA Resources.

Carnarvon Energy is gearing up for a high-impact Bedout Sub-basin drilling campaign in the first half of 2027, supported by a robust balance sheet and strategic investments.

EVE Health Group has appointed Ben Rohr as CEO, shifting Damian Wood to focus on regulatory and clinical affairs, aiming to sharpen commercial execution amid ongoing product rollouts.

Santana Minerals advanced its Bendigo-Ophir Gold Project in New Zealand with a confirmed consent decision date, major equipment agreements, and a substantial capital raise, setting the stage for development.

AuKing Mining has bolstered its project portfolio with the acquisition of a Tasmanian tin and silver licence and the Malawi-based Tundulu Rare Earths Project, supported by $5 million in recent equity placements.

Sabre Resources (ASX:SBR) has secured 80% stakes in two companies holding nearly 4,000km² of highly prospective gold and copper-gold projects in the Northern Territory, including drill-ready targets analogous to the Tennant Creek Mineral Field. A heavily supported $2 million placement will fund aggressive exploration including imminent drilling.

Kuniko Limited has launched a prospectus offering over 51 million new options following a $3.75 million share placement, aiming to facilitate secondary trading and potential future capital raising through option exercises.

Corella Resources has agreed to acquire a majority interest in the Chobe Project, a highly prospective niobium and rare earths ground in Western Australia’s West Arunta, supported by a heavily oversubscribed $5 million capital raise.

Chimeric Therapeutics' CHM CORE-NK cell therapy achieved a 60% complete response rate in high-risk frontline AML patients, significantly exceeding typical outcomes and maintaining a strong safety profile.

Diamond Infraco 1 Pty Ltd, backed by IFM Global Infrastructure Fund, has tabled an all-cash takeover offer for the remaining Atlas Arteria securities at A$4.75, rising to A$5.10 if a 45% stake is secured. The bid comes amid concerns over Atlas Arteria’s recent strategic pivot and operational underperformance.

Brazilian Rare Earths (ASX: BRE) has reported substantial expansion of its Monte Alto rare earth project with ultra high-grade drilling results and validated low-temperature processing delivering 97% recovery. The company also secured a Trial Mining Licence enabling early production and bulk shipments.

Biome Australia has taken a significant step in its innovation journey by filing a patent for its next generation probiotic strain BMB18, with a clinical trial set to begin in Q4 FY26 in partnership with La Trobe University.